BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 11677850)

  • 21. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
    Shaller D
    Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [An index of understanding randomised clinical trials in oncology].
    Leroy T; Christophe V; Penel N; Antoine P; Vanlemmens L; Reich M; Clisant S
    Bull Cancer; 2009 Jun; 96(6):741-50. PubMed ID: 19467958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development and perspectives of community DOTS].
    Narita T; Kobayashi N
    Kekkaku; 2009 Apr; 84(4):187-201. PubMed ID: 19425394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Addiction and brief-systemic therapy: working with compulsion].
    Cottencin O; Doutrelugne Y; Goudemand M; Consoli SM
    Encephale; 2009 Jun; 35(3):214-9. PubMed ID: 19540406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Contraceptive development--the view from the U.S.A. in the mid 80s].
    Potts M; Siemens A; Burton N
    Contracept Fertil Sex (Paris); 1986 Mar; 14(3):247-51. PubMed ID: 12268061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exception from informed consent: viewpoint of institutional review boards--balancing risks to subjects, community consultation, and future directions.
    Ernst AA; Fish S
    Acad Emerg Med; 2005 Nov; 12(11):1050-5. PubMed ID: 16264073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progress and problems for randomized clinical trials: from streptomycin to the era of megatrials.
    Hilbrich L; Sleight P
    Eur Heart J; 2006 Sep; 27(18):2158-64. PubMed ID: 16870690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "How much do you get paid if I volunteer?" Suggested institutional policy on reward, consent, and research.
    La Puma J; Kraut J
    Hosp Health Serv Adm; 1994; 39(2):193-203. PubMed ID: 10134417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Patients' perspective and economic variables as objectives in clinical trials: added value to clinical parameters].
    Bovaira-García MJ; Soler-Company E
    Rev Calid Asist; 2012; 27(2):92-102. PubMed ID: 22137201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Managing clinical grant costs.
    Glass HE; Hollander K
    Contemp Clin Trials; 2009 May; 30(3):221-6. PubMed ID: 19470309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to improve the clinical development paradigm and its division into phases I, II and III.
    Bamberger M; Moore N; Lechat P;
    Therapie; 2011; 66(4):331-4, 327-30. PubMed ID: 21851796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Trial Educator program - a novel approach to accelerate enrollment in a phase III International Acute Coronary Syndrome Trial.
    Kendall B; Städeli R; Schegg B; Olbrich M; Chen E; Harmelin-Kadouri R; Aurup P; Schwab T; Hildemann SK
    Clin Trials; 2012 Jun; 9(3):358-66. PubMed ID: 22426648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time to activate lung cancer clinical trials and patient enrollment: a representative comparison study between two academic centers across the atlantic.
    Wang-Gillam A; Williams K; Novello S; Gao F; Scagliotti GV; Govindan R
    J Clin Oncol; 2010 Aug; 28(24):3803-7. PubMed ID: 20644091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Quantitative bibliographic analysis of French clinical research in the treatment of bronchopulmonary cancer].
    Lebeau B
    Rev Mal Respir; 1998 Apr; 15(2):185-9. PubMed ID: 9608989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The process of clinical trials: a model for successful clinical trial participation.
    Lengacher CA; Gonzalez LL; Giuliano R; Bennett MP; Cox CE; Reintgen DS
    Oncol Nurs Forum; 2001 Aug; 28(7):1115-20. PubMed ID: 11517845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barriers to informed consent in clinical trials.
    Gallagher SM
    Ostomy Wound Manage; 1999 Nov; 45(11):14-6. PubMed ID: 10687654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [France, an attractive country for international clinical research: 2010 survey assessed by Leem (French association of pharmaceutical companies)].
    Lassale C; Sibenaler C; Behier JM; Pletan Y; Courcier S
    Therapie; 2011; 66(1):1-15. PubMed ID: 21466772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Survey for participation in therapeutic trials in psychiatry].
    Gérard-Coué MJ; Rouillon F; Dreyfus JD
    Encephale; 1994; 20(4):421-6. PubMed ID: 7988406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.